Literature DB >> 21317712

Endocervical fibroblastic malignant peripheral nerve sheath tumor (neurofibrosarcoma): report of a novel entity possibly related to endocervical CD34 fibrocytes.

Anne M Mills1, Jason R Karamchandani, Hannes Vogel, Teri A Longacre.   

Abstract

Primary cervical stromal sarcomas are rare neoplasms that have been poorly characterized. We report the clinical, histologic, and immunohistologic features of 3 primary endocervical S100 protein (S100p)-positive and CD34-positive sarcomas, herein designated as fibroblastic malignant peripheral nerve sheath sarcoma (endocervical neurofibrosarcoma), 2 of which occurred in women younger than 35 years of age. All tumors presented as a cervical polyp or mass lesion; 1 extended into the pelvic side wall and vaginal soft tissue. The tumors measured 2.0 to 8.0 cm, and were composed of compact fascicles of spindled cells arranged in herringbone, loose fascicular, or ill-defined storiform patterns. A focal whorled architecture was identified in all 3 tumors, but distinct Antoni A areas and Verocay bodies were absent. Ultrastructural examination in 1 case confirmed the presence of fibrocyte-like differentiation. Strong, diffuse, and in 1 case, patchy S100p expression was seen in all cases; strong and diffuse CD34 expression was also present in all tumors. Adjacent uninvolved endocervical stroma also showed CD34 positivity but expression was much less dramatic than in tumor cells. All other markers of neural, melanocytic, smooth muscle, endometrial stromal, and epithelial differentiation were negative. One of the tumors behaved extremely aggressively with extensive pelvic involvement, resulting in patient death within 16 months of diagnosis; another tumor was associated with pelvic recurrence 13 months after diagnosis; and the third tumor had an indolent course with no evidence of recurrence at 33 months after complete excision and local radiotherapy, although follow-up was limited. Review of large numbers of mesenchymal tumors in the uterus did not show similar tumors. Endocervical neurofibrosarcoma should be distinguished from solitary fibrous tumor, endometrial stromal sarcoma, leiomyosarcoma, melanoma, and other spindle cell neoplasms. The prominent fibroblastic endoneurial-like differentiation seen in this peripheral nerve sheath tumor may be related to the presence of a rich mucosal stromal fibrocyte network in the endocervix.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317712     DOI: 10.1097/PAS.0b013e318208f72e

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

1.  NTRK -Rearranged Uterine Sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.

Authors:  Danielle C Costigan; Marisa R Nucci; Brendan C Dickson; Martin C Chang; Sharon Song; Lynette M Sholl; Jason L Hornick; Christopher D M Fletcher; David L Kolin
Journal:  Am J Surg Pathol       Date:  2022-06-20       Impact factor: 6.298

Review 2.  The life and works of S100P - from conception to cancer.

Authors:  Filip Prica; Tomasz Radon; Yuzhu Cheng; Tatjana Crnogorac-Jurcevic
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

3.  NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: A case report.

Authors:  A E Wells; A M Mallen; M M Bui; D R Reed; S M Apte
Journal:  Gynecol Oncol Rep       Date:  2019-04-23

4.  NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.

Authors:  Sarah Chiang; Paolo Cotzia; David M Hyman; Alexander Drilon; William D Tap; Lei Zhang; Jaclyn F Hechtman; Denise Frosina; Achim A Jungbluth; Rajmohan Murali; Kay J Park; Robert A Soslow; Esther Oliva; A John Iafrate; Ryma Benayed; Marc Ladanyi; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.